ad

Fortis Malar Hospitals Q4 FY26 Results: Loss Rs 0.05 Cr, Revenue Rs 0.00 Crore

19 May 20263:31 pm

Fortis Malar Hospitals Q4 FY26 Results: Loss Rs 0.05 Cr, Revenue Rs 0.00 Crore
 

Fortis Malar Hospitals Q4 FY26 results were declared on May 18, 2026, at the board of directors meeting. Fortis Malar Hospitals reported a net loss of Rs 0.05 crore for the quarter ended March 31, 2026, Q4 FY26 (results declared May 18, 2026), on revenue of Rs 0.00 crore. Fortis Malar Hospitals operates in the multi-speciality hospital and healthcare services sector. Investors tracking Fortis Malar Hospitals Q4 FY26 will find a complete financial analysis and FY27 outlook in this article.

Click Here – Get Free Investment Predictions

Fortis Malar Hospitals Q4 FY26 Financial Highlights

Metric Q4 FY26 Comparison
Net Loss Rs 0.05 crore Q4 FY26 (results declared May 18, 2026)
Revenue from Operations Rs 0.00 crore Quarter ended March 31, 2026
Ticker   Sector: Healthcare

Fortis Malar Hospitals Q4 FY26 Performance Analysis

Fortis Malar Hospitals Q4 FY26 reflects the company's operational performance during the January to March 2026 quarter. Fortis Malar Hospitals is a leading multi-speciality hospital and healthcare services company whose Q4 FY26 print sets the baseline for FY27 guidance. The reported loss reflects ongoing challenges; management guidance on the FY27 recovery trajectory will be the key watch point. Q4 January to March is typically a seasonally strong quarter for Indian companies, driven by year-end government procurement and project completion cycles.

The path to profitability in FY27 depends on volume recovery, cost reduction, and strategic business initiatives. Track Fortis Malar Hospitals on the Univest Screener for live data.

Check the Univest Screener for live data

Key Factors for the Company

Revenue and Sector Dynamics

Fortis revenue of Rs 0.00 crore reflects the company's execution in the multi-specialty hospital and healthcare services space. India's sustained economic growth of 6.5%+ and robust domestic demand across sectors provide a supportive backdrop for FY27 business planning.

Profitability and Margin Trends

The company's net loss of Rs 0.05 crore Q4 FY26 (results declared May 18, 2026) demonstrates near-term margin challenges. The company's FY27 strategy to restore profitability through volume growth and cost optimisation will be closely monitored by investors.

FY27 Business Outlook

Following the firm results, management guidance on FY27 revenue, order book, and strategic priorities will be key catalysts. Download the Univest iOS App or Univest Android App to receive SEBI-registered analyst research on Fortis Malar Hospitals.

Frequently Asked Questions on Fortis

What is the company's PAT?

Ans. Fortis reported a net loss of Rs 0.05 crore Q4 FY26 (results declared May 18, 2026). Results declared May 18, 2026. Full details from NSE/BSE regulatory filings. Verify all data before investing.

What is the company's revenue?

Ans. The firm's revenue from operations was Rs 0.00 crore for the quarter ended March 31, 2026. Track live on the Univest Screener.

When were Fortis results announced?

Ans. The company results were announced on May 18, 2026, at the board meeting approving audited Q4 and FY26 financial statements for the year ended March 31, 2026.

Is Fortis Malar Hospitals a good investment after Q4 FY26?

Ans. Investment decisions require individual assessment of fundamentals, valuation, sector dynamics, and personal risk tolerance. This article does not constitute investment advice. Consult a SEBI-registered financial advisor before investing.

Investments in securities are subject to market risk. This content is for educational purposes only and does not constitute investment advice.

Recent Articles

Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.

Reviews

user-review-1
user-review-2
user-review-3
user-review-4
user-review-5
ad

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited

Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003

Write to us : support@univest.in, compliance@univest.in

Verify on SEBI registry →

RESEARCH ANALYST

Get SEBI Registered
advice on the stocks
trending today.

Get 3 FREE Trade Ideas

+91
for Startups Accelerator 2024

for Startups Accelerator 2024

Trusted by 1Cr Indians

Trusted by 1Cr Indians

Awarded No.1 by Economic Times

Awarded No.1 by Economic Times

GET THE APP

Join 1Cr users today.

SEBI Registered Analyst-backed Picks. Free Demat. One App

  • Free Demat account in under 5 minutes
  • Live market data — Nifty, Sensex, sector insights
  • SEBI Registered analyst-backed stock picks
Get it on Google PlayDownload on the App Store

Copyright 2026 Univest. All rights reserved.
Designed with ❤️ in India

arrow down